This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
13 Jun 2014  |  North America  |  Market Research
Analysis of the Western European Biomarkers Market in Drug Discovery and Development
Increasing Applications of Biomarkers are Driving Growth
This research service focuses on antiviral therapeutics for the treatment of the hepatitis C virus (HCV). A global product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HCV. Segmentation by drug class is provided, along with supporting information such as clinical trial t...
$4,950.00 -
11 Jun 2014  |  North America  |  Market Research
Vital Signs - Value Emerging as a New Currency in Medical Imaging Markets
Value Based Imaging
The concept of value-based imaging is certainly not new, but it has garnered considerable attention from the medical imaging community over the past few years. Confined until recently to the realm of thought leaders at luminary healthcare and advocacy organizations, the concept has gained wide momentum in the past year. Since medical imaging repres...
$450.00 -
11 Jun 2014  |  Global  |  Market Research
Analysis of the Western European Next Generation Sequencing (NGS) Market
Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...
$4,950.00 -
02 Jun 2014  |  Global  |  Market Research
Vital Signs - Healthcare News - The Analysts Perspective - May Issue
This issue of Vital Signs, released on June 2, 2014, discusses the latest strategy surrounding mega deals in the pharma/biotech industry, Eurofins agreement to acquire ViroCor-IBT Laboratories, Qiagens acquisition of BIOBASE, and the FDAs latest announcement on regulatory requirements for biosimilars.
$450.00 -
28 May 2014  |  Asia Pacific  |  Market Research
Profiling of Top 50 Healthcare Service Providers in Asia-Pacific
A Deep-dive Analysis of the Business and Financial Health of Leading Companies in the Region
Increased competition between healthcare providers which has lead to increased development of competitive features, such as premium care facilities, aesthetic and wellness medicine facilities, improved patient customer service, and so on. This has also stimulated the increased application of technology in both medical devices and information and c...
$4,950.00 -
26 May 2014  |  North America  |  Market Research
2014 American College of Cardiology (ACC) Review
Examining the Latest Industry Advances and Market Developments in Cardiovascular Imaging and Informatics
This study discusses the top themes and developments from the 2014 American College of Cardiology (ACC) annual meeting, focusing on the show floor and not the scientific sessions. It provides the US market size and growth for cardiovascular imaging equipment (interventional cardiology angiography x-ray, echocardiography ultrasound, and electrocardi...
$1,500.00 -
26 May 2014  |  Asia Pacific  |  Market Research
Indonesian Infectious Disease IVD Market
Mapping the Market for Investment, Best Practices, and Growth Potential
The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...
$4,950.00 -
26 May 2014  |  Europe  |  Market Research
Western Europe Hemostasis Diagnostics Market Data
Shortage of Laboratory Workforce is Driving Workflow Automation and Integration
This market insight provides market data for the Western European hemostasis diagnostics market. Market segments include instruments and reagents. Market revenues and installed base-units for total Western Europe, the United Kingdom, France, Germany, Italy, Spain, Nordic countries, and Benelux have been included in this deliverable. Further analysi...
$3,950.00 -
23 May 2014  |  Asia Pacific  |  Market Research
Western European Companion Diagnostics Market
Regulatory Hurdles and LDTs Stall the Global and European Market for Companion Diagnostics
The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...
$4,950.00 -
23 May 2014  |  Europe  |  Market Research
Regulatory Trends in the US Life Sciences Industry
Efficiency of FDA Review Process Expedites Access to Care
Biomarkers will certainly change the way healthcare is provided. They are being increasingly used in early drug development and for clinical use as well, boosting their demand. The penetration of biomarkers in various therapeutic applications, the impact of market trends and dynamics are analysed in this study. This research service offers market o...
$1,500.00